Lantus Solostar Sales Data
| Rank 11 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Lantus Solostar U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 11 ( 1) |
$839,691 | 9.39% | 5,059 | 1.95% |
| Q3 2013 | 12 (3) |
$767,612 | 12.47% | 4,962 | -0.32% |
| Q2 2013 | 15 (2) |
$682,489 | 7.11% | 4,978 | 1.01% |
| Q1 2013 | 17 (1) |
$637,157 | 6.60% | 4,928 | 5.57% |
| Q4 2012 | 18 (1) |
$597,688 | 11.58% | 4,668 | 4.48% |
| Q3 2012 | 19 (7) |
$535,660 | 11.36% | 4,468 | 14.07% |
| Q2 2012 | 26 (3) |
$481,022 | 7.28% | 3,917 | 4.82% |
| Q1 2012 | 29 (5) |
$448,388 | 9.81% | 3,737 | 7.32% |
| Q4 2011 | 34 | $408,336 | 8.54% | 3,482 | 7.07% |
| Q3 2011 | 34 (2) |
$376,208 | 4.53% | 3,252 | 6.00% |
| Q2 2011 | 36 (5) |
$359,907 | 7.80% | 3,068 | 8.30% |
| Q1 2011 | 41 | $333,878 | n/a | 2,833 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
